Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do platelets play any role in the development of adenomyosis? SUMMARY ANSWER: As in endometriosis, adenomyotic lesions show significantly increased platelet aggregation, increased expression of transforming growth factor (TGF)-β1, phosphorylated Smad3, markers of epithelial-mesenchymal transition (EMT) and fibroblast-to-myofibroblast transdifferentiation (FMT), and smooth muscle metaplasia (SMM), in conjunction with increased fibrosis as compared with normal endometrium. WHAT IS KNOWN ALREADY: Both EMT and FMT are known to play vital roles in fibrogenesis in general and in endometriosis in particular. EMT has been implicated in the development of adenomyosis. SMM is universally seen in endometriosis and also in adenomyosis, and is correlated positively with the extent of fibrosis. However, there has been no published study on the role of platelets in fibrogenesis in adenomyosis, even though adenomyotic lesions undergo repeated cycles of tissue injury and repair, which suggests the involvement of platelets and their possible roles in fibrogenesis. STUDY DESIGN, SIZE, DURATION: Cross-sectional studies of ectopic endometrial and control endometrial tissue samples from three sets of women with and without adenomyosis (n= 34 and 20, 12 and 10, and 8 and 8, respectively) were carried out from 2014 to 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: Immunohistochemistry analysis of ectopic endometrial tissues from women with (n= 34) and without (n= 20) adenomyosis with respect to biomarkers of EMT, FMT and highly differentiated smooth muscle cells as well as TGF-β1, phosphorylated Smad3, markers of proliferation, angiogenesis and extracellular matrix (ECM) deposits. Masson trichrome staining, Van Gieson staining and Pico-Sirius staining were performed to evaluate and quantify the extent of fibrosis in lesions. Progesterone receptor isoform B (PR-B) staining also was performed. In addition, CD42b-positive platelets in ectopic (n= 12) and control (n= 10) endometrium were counted by confocal microscopy and compared. The protein expression levels of TGF-β1 and phosphorylated Smad3 in both ectopic (n= 8) and control (n= 8) endometrium were measured by western blot analysis. Immunofluorescent staining of both platelets and hepatocyte growth factor (HGF) was also performed for adenomyotic tissue samples (n= 10). MAIN RESULTS AND THE ROLE OF CHANCE: Adenomyotic lesions had a significantly higher extent of platelet aggregation and increased staining for TGF-β1 and phosphorylated Smad3 (both P-values <0.001 versus control). In addition, E-cadherin staining was decreased while vimentin staining in adenomyotic epithelial cells was increased, along with increased staining of proliferating cell nuclear antigen, vascular endothelial growth factor and CD31 (all P-values <0.001), markers of proliferation and angiogenesis. Staining for α-SMA, a marker for myofibroblast, desmin, smooth muscle myosin heavy chain and oxytocin receptor was significantly increased in adenomyotic lesions versus control, concomitant with increased staining of collagen I and lysyl oxidase (all P-values <0.001). Histochemistry analysis indicates that the extent of fibrosis is high in adenomyotic lesions (P < 0.001), and the extent appeared to correlate negatively with the microvessel density (P < 0.05). PR-B staining was significantly decreased in adenomyotic lesion as compared with control endometrium (P < 0.001). Platelets and HGF were co-localized mostly in the stromal component of adenomyotic lesions, near the glandular epithelium. LIMITATIONS, REASONS FOR CAUTION: The results are limited by the cross-sectional nature of the study and the use of histochemistry and immunohistochemistry analyses only, but nonetheless is a validation of our previous finding in mouse experiments. WIDER IMPLICATIONS OF THE FINDINGS: The data presented are consistent with the notion that platelet-induced activation of the TGF-β/Smad signaling pathway may be a driving force in EMT, FMT and SMM in the development of adenomyosis, leading to fibrosis. This study provides the first piece of evidence that adenomyotic lesions are wounds that undergo repeated injury and healing, and, as such, platelets play critical roles in the development of adenomyosis by promoting proliferation, angiogenesis, increasing ECM deposits, and SMM, resulting in fibrosis. Platelets may also be involved in uterine hyperactivity and myometrial hyperinnervation. Our results provide one explanation as to why adenomyosis is a challenge for medical treatment, and shed new light onto the pathophysiology of adenomyosis. STUDY FUNDING/COMPETING INTERESTS: Support for data collection and analysis was provided by grants from the National Science Foundation of China. None of the authors has anything to disclose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the extent of lesional fibrosis is a proxy for lesional developmental stage (Guo et al., 2015; Liu et al., 2016; Shen et al., 2016; Zhang et al., 2016)”
From Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium (2025) · cites this paper as Liu et al., 2016
In the citing paper
“As adenomyosis shares with endometriosis in cyclic bleeding and thus ReTIAR, the two diseases also share common key molecular events in lesional development, i.e., EMT, fibroblast-to-myofibroblast transdifferentation, smooth muscle metaplasia, and fibrogenesis [105,106].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [105]
In the citing paper
“regardless of subtypes, all endometriotic lesions appear to undergo identical molecular processes such as epithelial-mesenchymal transition (EMT), fibroblast-to-myofibroblast transdifferentiation (FMT), smooth muscle metaplasia (SMM), and fibrogenesis25,26,53, even in adenomyotic lesions81,82.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [81]
In the citing paper
“As a corollary, OE and DE, and likely other subtypes of endometriosis and adenomyosis as well91,92, have the identical pathophysiology and similar natural history as wounds undergoing ReTIAR.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [91]
Citations
Cites
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,708
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 3×
“In addition, while EMT is known to occur in tissue repair (Thiery et al., 2009) and often leads to fibrosis (Nawshad et al., 2004), it is unclear whether fibrosis also is present in adenomyosis as in endometriosis (Matsuzaki and Darcha, 2013).”
BackgroundR: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. C. (1996) · Journal of Computational and Graphical Statistics · doi:10.2307/1390807 · Cited by 4,245
Formation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658 · cited 1×
“It also involves myofibroblast activation so that fibroblasts acquire a migratory phenotype in order to re-populate the damaged tissues (Hinz, 2007).”
BackgroundCommon and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456 · cited 2×
“However, with repeated and persistent tissue injury and then repair, the normal, physiological wound-healing response can go awry (Wynn, 2007), resulting in excessive ECM deposits, leading to fibrosis (Thannickal et al., 2014).”
BackgroundCoppinger, J. A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., McRedmond, J. P., Cahill, D. J., Emili, A., Fitzgerald, D. J., & Maguire, P. B. (2004) · Blood · doi:10.1182/blood-2003-08-2804 · Cited by 814 · cited 4×
“Following platelet activation, hundreds of biologically active molecules, including HGF (Nakamura et al., 1986; Matsuo et al., 2008), are released and deposited at the sites of a wound (Coppinger et al., 2004) and, as shown in Fig.”
BackgroundInfluentialNeutrophils scan for activated platelets to initiate inflammation
Sreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Bilbao, I., Nácher, M., Pitaval, C., Radovanovic, I., Fukui, Y., et al. (2014) · Science · doi:10.1126/science.1256478 · Cited by 650 · cited 1×
“Activated platelets were found to play a critical role in initiating inflammation (Sreeramkumar et al., 2014).”
BackgroundNakamura, T., Teramoto, H., & Ichihara, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6489 · Cited by 582 · cited 2×
“Following platelet activation, hundreds of biologically active molecules, including HGF (Nakamura et al., 1986; Matsuo et al., 2008), are released and deposited at the sites of a wound (Coppinger et al.”
BackgroundPathology and physiopathology of adenomyosis
Bergeron, C., Amant, F., & Ferenczy, A. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.016 · Cited by 359 · cited 3×
“Treatment of adenomyosis is challenging, with hysterectomy being the treatment of choice (Bergeron et al., 2006).”
Background
Cited by
Pathogenesis of uterine adenomyosis, invagination or metaplasia?
García-Solares, J., Donnez, J., Donnez, O., & Dolmans, M.-M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.12.030 · Cited by 339
Pathogenesis of adenomyosis, an update on molecular mechanisms
Vannuccini, S., Tosti, C., Carmona, F., Huang, S. J., Chapron, C., Guo, S.-W., & Petraglia, F. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.06.016 · Cited by 326
“This is consistent with the recent finding that platelets are aggregated in adenomyotic lesions (Liu et al., 2016) (Figure 2).”
Self-citationAdenomyosis: Mechanisms and Pathogenesis
Zhai, J., Vannuccini, S., Petraglia, F., & Giudice, L. C. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1716687 · Cited by 292
Chapron, C., Tosti, C., Marcellin, L., Bourdon, M., Lafay-Pillet, M.-C., Millischer, A.-E., Streuli, I., Borghese, B., Petraglia, F., & Santulli, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex088 · Cited by 294
Zhang, Q., Duan, J., Liu, X., & Guo, S.-W. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.015 · Cited by 211
Self-citationImmunological changes associated with adenomyosis: a systematic review
Bourdon, M., Santulli, P., Jeljeli, M., Vannuccini, S., Marcellin, L., Doridot, L., Petraglia, F., Batteux, F., & Chapron, C. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa038 · Cited by 183
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
Jain, V., Chodankar, R. R., Maybin, J. A., & Critchley, H. O. D. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00629-4 · Cited by 165
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Guo, S.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020485 · Cited by 165
“, EMT, fibroblast-to-myofibroblast transdifferentation, smooth muscle metaplasia, and fibrogenesis [105,106].”
BackgroundSelf-citationZhang, Q., Duan, J., Olson, M., Fazleabas, A., & Guo, S.-W. (2016) · Reproductive Sciences · doi:10.1177/1933719116641763 · Cited by 149
Self-citationAghajanova, L., Houshdaran, S., Balayan, S., Manvelyan, E., Irwin, J. C., Huddleston, H. G., & Giudice, L. C. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1130-8 · Cited by 146
“In contrast to our findings with eSF from women without any gynecologic disorder, prolonged exposure of endometriotic and adenomyosis lesions to activated platelets results in fibrosis due to epithelial-to-mesenchymal transition, fibroblast-tomyofibroblast transdifferentiation, and repeated injury and healing [59, 60].”
ResultHarmsen, M. J., Wong, C. F. C., Mijatovic, V., Griffioen, A. W., Groenman, F. A., Hehenkamp, W. J. K., & Huirne, J. A. F. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz024 · Cited by 172
Guo, S.-W. (2018) · Human Reproduction · doi:10.1093/humrep/dey015 · Cited by 116
Self-citationLiu, X., Zhang, Q., & Guo, S.-W. (2018) · Reproductive Sciences · doi:10.1177/1933719117718275 · Cited by 110
“Similar processes also seem to occur in adenomyosis, which also shares the commonality of cyclic bleeding as in endometriosis.(25,26) Although the ReTIAR theory seems to account for agedependent changes in lesion coloration(18) and also offers a possibility for histological staging of endometriotic lesions,(19,27) it…”
BackgroundSelf-citationCancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology
Guo, S.-W. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz047 · Cited by 96
“The same processes also are operative in adenomyosis because of the commonality of cyclic bleeding (Liu et al., 2016; Shen et al., 2016).”
BackgroundSelf-citationIs it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
Guo, S.-W., & Groothuis, P. G. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy020 · Cited by 95
“In addition, given the fibroproliferative nature of endometriotic lesions (Vigano et al., 2017; Guo, 2018) as well as adenomyotic lesions (Liu et al., 2016b, 2018a, c, Shen et al., 2016), there is a real question as to whether SPRMs can have any impact on advanced endometriosis/adenomyosis.”
BackgroundSelf-citationEnhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
Zhang, Q., Dong, P., Liu, X., Sakuragi, N., & Guo, S.-W. (2017) · Scientific Reports · doi:10.1038/s41598-017-06920-7 · Cited by 88
Self-citationContemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2
Jain, V., Munro, M. G., & Critchley, H. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14946 · Cited by 119
Yan, D., Liu, X., & Guo, S.-W. (2019) · Scientific Reports · doi:10.1038/s41598-019-39170-w · Cited by 82
Self-citationCracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology
Guo, S. (2022) · Reproduction · doi:10.1530/rep-22-0224 · Cited by 100
Self-citationPhenotypic characterization of adenomyosis occurring at the inner and outer myometrium
Kishi, Y., Shimada, K., Fujii, T., Uchiyama, T., Yoshimoto, C., Konishi, N., Ohbayashi, C., & Kobayashi, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189522 · Cited by 74
Transvaginal Elastosonography as an Imaging Technique for Diagnosing Adenomyosis
Liu, X., Ding, D., Ren, Y., & Guo, S. (2018) · Reproductive Sciences · doi:10.1177/1933719117750752 · Cited by 83
Self-citationPathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility
Khan, K. N., Fujishita, A., & Mori, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144057 · Cited by 82
“This was supported by the fact that platelet aggregation was correlated with the induction of EMT through activation of the TGF-β1/Smad3 signaling pathway in human adenomyosis [91].”
BackgroundYao, Q., Zheng, Y., Lan, Q.-H., Wang, L., Huang, Z., Chen, R., Yang, Y., Xu, H., Kou, L., & Zhao, Y. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105316 · Cited by 71
Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease?
Maruyama, S., Imanaka, S., Nagayasu, M., Kimura, M., & Kobayashi, H. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.08.019 · Cited by 81
“Inflammation and activated platelets also promote EMT-induced smooth muscle metaplasia and play an important role in the pathogenesis of adenomyosis [42].”
BackgroundOrigin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far
Stratopoulou, C. A., Donnez, J., & Dolmans, M. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00361-w · Cited by 79
Geyikoğlu, F., Emir, M., Çolak, S., Koç, K., Türkez, H., Bakır, M., Hosseinigouzdagani, M., Çeriğ, S., Keleş, O. N., & Özek, N. Ş. (2016) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.07.002 · Cited by 75
“[54] Liu X, Shen M, Qi Q, Zhang H, Guo SW.”
BackgroundConservative management of uterine adenomyosis: medical vs. surgical approach
Stratopoulou, C. A., Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214878 · Cited by 62
“One mouse model-based study suggested the potential utility of ozagrel, an antiplatelet drug, for treatment of adenomyosis, after observing enhanced platelet aggregation in mouse and human lesions [71,72].”
BackgroundAnti-platelet therapy holds promises in treating adenomyosis: experimental evidence
Zhu, B., Chen, Y., Shen, X., Liu, X., & Guo, S.-W. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0198-1 · Cited by 60
Self-citationCancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
Guo, S. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12221 · Cited by 60
Self-citationXiao, F., Liu, X., & Guo, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610963 · Cited by 67
“Human breast cancer tissue samples were used for staining of GARP (44), ovarian endometrioma tissue samples were used for CD68 (45), p-Smad3 (9), and p-Akt (46), deep endometriosis tissue samples were used for TGF-b1, normal endometrium tissue samples were used for E-cadherin (9), and human adenomyosis tissue samples…”
MethodSelf-citationEndometriosis and adenomyosis: Similarities and differences
Donnez, J., Stratopoulou, C. A., & Dolmans, M.-M. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102432 · Cited by 57
Yen, C., Huang, S.-T. J., Lee, C., Wang, H., & Liao, S. (2017) · Reproductive Sciences · doi:10.1177/1933719117691141 · Cited by 60
“These findings suggest that the activation of TGF-b/Smad signaling pathway may be a driving force in EMT, FMT, and SMM in the development of adenomyosis, leading to the coexisting fibrosis.(45) These results could also arouse several considerations regarding the origin of these myofibroblast-like cells.”
BackgroundResultInfluentialSensory nerve-derived neuropeptides accelerate the development and fibrogenesis of endometriosis
Liu, X., Yan, D., & Guo, S.-W. (2019) · Human Reproduction · doi:10.1093/humrep/dey392 · Cited by 51
Self-citationSubtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma
Wu, X., Serna, V. A., Thomas, J. W., Qiang, W., Blumenfeld, M. L., & Kurita, T. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1744 · Cited by 50
“In addition, ACTA2, the most commonly used SMC marker, cannot accurately detect the disappearance of SMCs from cell cultures, as ACTA2 can be induced in non-SMCs of the human uterus (35-39).”
Evidence in Support for the Progressive Nature of Ovarian Endometriomas
Ding, D., Wang, X., Chen, Y.-S., Benagiano, G., Liu, X., & Guo, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa189 · Cited by 49
Self-citationHow does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding?
Huang, Q., Liu, X., Critchley, H., Fu, Z., & Guo, S. (2022) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12442 · Cited by 51
Self-citationFGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway
Li, H., Cai, E., Cheng, H., Ye, X., Ma, R., Zhu, H., & Chang, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.791860 · Cited by 52
Qi, Q., Liu, X., Zhang, Q., & Guo, S.-W. (2020) · Scientific Reports · doi:10.1038/s41598-020-57997-6 · Cited by 44
Self-citationAn, M., Li, D., Yuan, M., Li, Q., Zhang, L., & Wang, G. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.144071 · Cited by 80
“The experiment detected this phenomenon [6,12,30] by IHC staining.”
BackgroundMethodVannuccini, S., Jain, V., Critchley, H., & Petraglia, F. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.021 · Cited by 62
Uterine disorders and iron deficiency anemia
Donnez, J., Carmona, F., Maitrot‐Mantelet, L., Dolmans, M., & Chapron, C. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.08.011 · Cited by 61
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
Harada, T., Taniguchi, F., Guo, S., Choi, Y. M., Biberoglu, K. O., Tsai, S. S., Alborzi, S., Al‐Jefout, M., Chalermchockcharoenkit, A., Sison-Aguilar, A. G., et al. (2023) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12535 · Cited by 55
Self-citationTan, J., Yong, P. J., & Bedaiwy, M. A. (2019) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000555 · Cited by 50
“This dysregulated cell-to-cell communication may also be induced by platelet aggregation and activation [9].”
BackgroundBiomarkers in abnormal uterine bleeding†
Chodankar, R. R., & Critchley, H. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy231 · Cited by 48
“be involved in uterine hyperactivity and myometrial hyperinnervation, potentially contributing to adenomyosis symptoms [39].”
BackgroundHao, M., Liu, X., & Guo, S. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.07.023 · Cited by 42
Self-citationAdenomyosis and Adolescence: A Challenging Diagnosis and Complex Management
Martire, F. G., d’Abate, C., Schettini, G., Cimino, G., Ginetti, A., Colombi, I., Cannoni, A., Centini, G., Zupi, E., & Lazzeri, L. (2024) · Diagnostics · doi:10.3390/diagnostics14212344 · Cited by 46
“This process progresses to fibrosis through epithelial–mesenchymal transition (EMT), fibroblast-to-myofibroblast transdif-ferentiation (FMT), and smooth muscle metaplasia (SMM) [18,19].”
BackgroundWu, Y., Zhang, Z., Li, J., Zhong, H., Yuan, R., Deng, Z., & Wu, X. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10311-x · Cited by 39
β-catenin activates TGF-β-induced epithelial–mesenchymal transition in adenomyosis
Yoo, J., Ku, B. J., Kim, T. H., Ahn, J. I., Ahn, J. Y., Yang, W. S., Lim, J. M., Taketo, M. M., Shin, J., & Jeong, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00514-6 · Cited by 42
Chen, Y.-S., Lin, S., Xie, X., Yi, J., Liu, X., & Guo, S. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102433 · Cited by 42
Self-citationCheong, M.-L. J., Lai, T., & Wu, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210765 · Cited by 69
Anti-platelet therapy is efficacious in treating endometriosis induced in mouse
Guo, S., Ding, D., & Liu, X. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.07.007 · Cited by 35
Self-citationCao, Y., Liu, X., & Guo, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45785-w · Cited by 38
Self-citationPhysiomimetic Models of Adenomyosis
Gnecco, J. S., Brown, A. T., Kan, E. L., Baugh, L. M., Ives, C., Loring, M., & Griffith, L. G. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1719084 · Cited by 34
Mechanisms and Pathogenesis of Adenomyosis
Rossi, M., Vannuccini, S., Capezzuoli, T., Fambrini, M., Vannuzzi, V., Donati, C., & Petraglia, F. (2022) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-022-00326-7 · Cited by 42
Bourdon, M., Santulli, P., Doridot, L., Jeljeli, M. M., Chêne, C., Chouzenoux, S., Nicco, C., Marcellin, L., Chapron, C., & Batteux, F. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab053 · Cited by 34
The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review
Moawad, G., Youssef, Y., Fruscalzo, A., Faysal, H., Kheil, M. H., Pirtea, P., Guani, B., Ayoubi, J. M., & Féki, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196130 · Cited by 35
“GnRH agonists are also indicated to improve the chances of pregnancy in women with adenomyosis [56].”
BackgroundDiagnosing deep endometriosis using transvaginal elastosonography
Ding, D., Chen, Y., Liu, X., Jiang, Z., Cai, X., & Guo, S.-W. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00108-2 · Cited by 28
“Since adenomyotic lesions are also wounds undergoing ReTIAR [37, 38] just like endometriotic lesions [39], we hypothesized that DE lesions can also be diagnosed with TVESG with more accuracy.”
BackgroundSelf-citationYang, M., Yu, R., Chen, W., Chen, J., & Wang, Z. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2021.663128 · Cited by 28
“Liu found that platelet count was related to the formation and development of adenomyosis, and the increase of platelet count may promote tissue fibrosis (42).”
BackgroundThe Menstrual Endometrium: From Physiology to Future Treatments
Watters, M., Martínez-Aguilar, R., & Maybin, J. A. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2021.794352 · Cited by 30
“The microvascular density of both the eutopic endometrium and adenomyotic lesions was higher than in the endometrium of healthy controls (70, 71).”
BackgroundResearch Advances in Adenomyosis-Related Signaling Pathways and Promising Targets
Zhang, H., Li, C., Li, W., Xin, W., & Qin, T. (2024) · Biomolecules · doi:10.3390/biom14111402 · Cited by 33
“Tissue damage repair, ECM deposition, EMT, fibroblast-to-myofibroblast transdifferentiation (FMT), smooth muscle metaplasia (SMM), and immune responses are all key contributors to the fibrotic process in adenomyosis [72,73].”
Self-citationHu, R., Guo-qing, P., Ban, D., Zhang, C., Zhang, X., & Li, Y. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00035-2 · Cited by 27
Wang, Y., Duan, H., Wang, S., Quan, Y., Huang, J., & Guo, Z. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00444-8 · Cited by 29
Ma, L., Andrieu, T., McKinnon, B. D., Duempelmann, L., Peng, R., Wotzkow, C., Mueller, C., & Mueller, M. D. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105943 · Cited by 31
“of PR in endometrium, negatively correlated with EMT markers in adenomyosis lesions [33].”
Donnez, J., Donnez, O., Tourniaire, J., Brethous, M., Bestel, E., Garner, E. I. O., Charpentier, S., Humberstone, A., & Loumaye, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245794 · Cited by 29
“Progestogens and combined oral contraceptives are not very effective, as progesterone resistance in adenomyotic endometrium and stroma is considered another characteristic of uterine adenomyosis, similar to observations in deep endometriotic nodules that are frequently associated with uterine adenomyosis [4,5,12,23,24…”
BackgroundPossible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
Xu, X., Cai, X., Liu, X., & Guo, S. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00711-6 · Cited by 33
“In addition, neuropeptides such as SP and CGRP and their receptors have recently been shown to play a promotional role in endometriosis progression and fibrogenesis [44, 45], a feature also shared by adenomyosis [14, 55].”
BackgroundResultSelf-citationIdentifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis
Stratopoulou, C. A., Camboni, A., Donnez, J., & Dolmans, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194585 · Cited by 30
Teranishi, R., Takahashi, T., Obata, Y., Nishida, T., Ohkubo, S., Kazuno, H., Saito, Y., Serada, S., Fujimoto, M., Kurokawa, Y., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34461 · Cited by 25
The Effects of Anti-TGF-β1 on Epithelial–Mesenchymal Transition in the Pathogenesis of Adenomyosis
Kay, N., Huang, C., Shiu, L., Yu, Y.-C., Chang, Y., Suen, J., Tsai, E., & Huang, S.-T. J. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00139-0 · Cited by 27
Various types of adenomyosis and endometriosis: in search of optimal management
Guo, S. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.021 · Cited by 27
Self-citationEstablishment of Adenomyosis Organoids as a Preclinical Model to Study Infertility
Juárez‐Barber, E., Francés‐Herrero, E., Corachán, A., Vidal, C., Gilés, J., Alamá, P., Faus, A., Pellicer, A., Cervelló, I., & Ferrero, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020219 · Cited by 29
“Further, patients with adenomyosis present increased TGF-β2 and SMAD3 levels in their eutopic endometrium during the secretory phase compared with disease-free women [32,33,37]] SMAD3.”
BackgroundKobayashi, H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043762 · Cited by 28
“, sis, sc l enesis) ere increased [11,32].”
BackgroundInfluentialBiological differences between focal and diffuse adenomyosis and response to hormonal treatment
Khan, K. N., Fujishita, A., Koshiba, A., Mori, T., Kuroboshi, H., Ogi, H., Itoh, K., Nakashima, M., & Kitawaki, J. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.12.015 · Cited by 25
Wu, H., Tsai, T.-C., Liu, S.-M., Pai, A. H.-Y., & Chen, L.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168937 · Cited by 24
Kay, N., Huang, C., Shiu, L., Yu, Y.-C., Chang, Y., Schatz, F., Suen, J., Tsai, E., & Huang, S.-T. J. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00308-1 · Cited by 22
The pathogenesis of endometriosis and adenomyosis: insights from single-cell RNA sequencing
Li, Q., Shi, J., Dai, Y., Li, X., Gu, Z., Yan, H., & Leng, J. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae032 · Cited by 29
“Compared with the normal endometrium, increased fibrosis has been identified in both endometriosis and adenomyotic lesions [51].”
BackgroundIwasawa, T., Takahashi, T., Maeda, E., Ishiyama, K., Takahashi, S., Suganuma, R., Matsuo, K., Tachibana, M., Fukuhara, R., Shirasawa, H., et al. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00764-7 · Cited by 19
“There are several theories on the origins of adenomyosis, such as direct invasion [3], tissue injury and repair [4], Müllerian remnants that develop into de novo ectopic endometrial tissue [3], endometrial stem/progenitor cells [5], and epithelial-to-mesenchymal transition [6, 7].”
BackgroundHarmsen, M. J., Arduç, A., Bleeker, M. C. G., Juffermans, L. J. M., Griffioen, A. W., Jordanova, E. S., & Huirne, J. A. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158434 · Cited by 19
“, on ectopic endometrial tissue samples that, in cases of advanced adenomyosis, myometrial hypertrophy results in fibrosis and a concomitant decrease in vascular density [9].”
BackgroundMethodAdenomyosis and Abnormal Uterine Bleeding: Review of the Evidence
Habiba, M. A., Guo, S., & Benagiano, G. (2024) · Biomolecules · doi:10.3390/biom14060616 · Cited by 28
Self-citationUnveiling the Pathogenesis of Adenomyosis through Animal Models
Wang, X., Benagiano, G., Liu, X., & Guo, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061744 · Cited by 19
Self-citationExtracellular vesicles contribute to EMT in adenomyosis by inducing macrophage polarization
Hu, Y., Yuan, M., Cheng, L., & Wang, G. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad015 · Cited by 21
“Earlier reports illustrated that estrogen dependence, platelet aggregation, and activation may be responsible for EMT induction in adenomyosis; on the other hand, the activation of immune cells and the release of immune soluble factors in adenomyosis were reported to be in conjunction with hormonal aberrations and act…”
BackgroundJin, T., Li, M., Li, T., Yan, S., Ran, Q., & Chen, W. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01189-w · Cited by 18
Research Progress of PCNA in Reproductive System Diseases
Pan, J., & Zhang, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2391917 · Cited by 20
Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis
Lin, Q., Li, T., Ding, S., Yu, Q., & Zhang, X. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154382 · Cited by 16
“Ectopic endometriumassociated platelets in endometriosis and adenomyosis may be related to the increase in platelets [10,13].”
BackgroundThe Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis
Guo, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030842 · Cited by 21
Self-citationXu, X., Xing, Q., Liu, R., Liu, D., Yu, Z., Wang, Y., Zhou, P., Zhang, Y. V., Wang, J., Cao, Y., et al. (2022) · Stem Cells International · doi:10.1155/2022/5744538 · Cited by 19
Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction
Wang, X., Li, J., Lu, W., Gao, F., Zhang, S., & Li, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374382 · Cited by 31
Investigation of the role of platelets in the aetiopathogenesis of adenomyosis
Mosele, S., Stratopoulou, C. A., Camboni, A., Donnez, J., & Dolmans, M. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.01.009 · Cited by 17
The role of reproductive tract microbiota in gynecological health and diseases
Wang, Z., Zhang, L., Liu, X., & Xu, L. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104418 · Cited by 18
Self-citationLi, C., Xu, X., Zhao, X., & Du, B. (2025) · mSystems · doi:10.1128/msystems.00202-25 · Cited by 24
“Additionally, the levels of CA125, previously investigated as potential biomarkers for adenomyosis (37–39), endometriosis (40), as well as endometrial and ovarian cancers (41, 42), did not show significant differences among the endometrial samples in our cohort.”
Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis
Liu, W., Sheng, S., Zhu, C., Li, C., Zou, Y., Yang, C., Chen, Z., Wang, F., & Jiao, X. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.02.003 · Cited by 16
Jin, Z., Wu, X., Liu, H., & Xu, C. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8580 · Cited by 20
“Consistent with previous studies (48), reduced E-cadherin expression and increased N-cadherin expression were detected in the epithelial cells of adenomyotic lesions compared with normal endometrium in the present study, suggesting that invasiveness and progression of adenomyotic lesions could be regulated by EMT.”
Fang, Z., Wang, Q., Duan, H., Sheng, X., Qi, X., Xing, K., Liu, B., Chang, D., Guo, Y., Wang, X., et al. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31153 · Cited by 20
“Recent studies have shown that TGF ‐ β 1 expression is elevated in endometrium affected by endometritis and promotes the occurrence and development of fibrosis (Abudukeyoumu et al., 2020; Liu et al., 2016).”
BackgroundZipponi, M., Cacciottola, L., & Dolmans, M. (2024) · Human Reproduction · doi:10.1093/humrep/deae116 · Cited by 16
Adenomyosis-associated infertility: an update of the immunological perspective
Cao, Y., Yang, D., Cai, S., Yang, L., Yu, S., Geng, Q., Mo, M., Li, W., Wei, Y., Li, Y., et al. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104703 · Cited by 23
Cai, X., Shen, M., Liu, X., & Nie, J. (2018) · Reproductive Sciences · doi:10.1177/1933719118773490 · Cited by 23
“Finally, coagulant parameters were also determined with supportive analysis of their relationship with eIF3e expression in light of the fact that platelets play an important role in endometriosis(19,20) and adenomyosis development.(6,21)”
BackgroundMethodSelf-citationWang, S., Li, B., Duan, H., Wang, Y., Shen, X., & Dong, Q. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.11.002 · Cited by 14
Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science
Groothuis, P. G., & Guo, S.-W. (2018) · Reproductive Sciences · doi:10.1177/1933719118785767 · Cited by 13
Self-citationPrecancerous niche (PCN), a product of fibrosis with remodeling by incessant chronic inflammation
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018009 · Cited by 16
Jiang, C., Liu, C., Guo, J., Chen, L., Luo, N., Qu, X., Yang, W., Ren, Q., & Cheng, Z. (2017) · Medicine · doi:10.1097/md.0000000000006880 · Cited by 15
Uterine Collagen Cross-Linking: Biology, Role in Disorders, and Therapeutic Implications
Kurt, I., Külhan, M., AlAshqar, A., & Borahay, M. A. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01386-7 · Cited by 19
“However, surprisingly, the extent of fibrosis in these tissues positively correlated exclusively with type I collagen levels [173].”
Metadata
- Authors
- Liu, X., Shen, M., Qi, Q., Zhang, H., & Guo, S.-W.
- Affiliations
- Fudan University (CN)
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Guo, Sun-Wei
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-22
- Volume
- 31
- Issue
- 4
- Pages
- 734-749
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2303031632
- Cited by
- 190
- References
- 98
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 47 · 2023: 19 · 2022: 22 · 2021: 18 · 2020: 21 · 2019: 9 · 2018: 14 · 2017: 8 · 2016: 6
- FWCI
- 16.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Science Foundation of China (2013ZYJB0019)
- Shanghai Municipal Commission of Health and Family Planning
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- adenomyosis, platelets, epithelial-mesenchymal transition, fibroblast-to-myofibroblast transdifferentiation, TGF-β1, Smad3 phosphorylation, fibrosis, endometrium, CD42b, extracellular matrix, angiogenesis, fibrogenesis
- MeSH terms
- Adult, Blood Platelets, Cells, Cultured, Cross-Sectional Studies, Endometrium, Female, Fibroblasts, Fibrosis, Humans, Middle Aged, Myometrium, Neovascularization, Pathologic, Platelet Aggregation, Biomarkers, Cell Proliferation, Cell Transdifferentiation, Microvessels, Myofibroblasts, Epithelial-Mesenchymal Transition, Adenomyosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.